Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ICUI Stock Forecast 2025-2026
$128.99
Current Price
$3.17B
Market Cap
Buy 5
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to ICUI Price Targets
+55.1%
To High Target of $200.00
+45.0%
To Median Target of $187.00
+35.7%
To Low Target of $175.00
ICUI Price Momentum
-8.8%
1 Week Change
-6.0%
1 Month Change
+26.9%
1 Year Change
-16.9%
Year-to-Date Change
-34.3%
From 52W High of $196.26
+27.8%
From 52W Low of $100.91
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching ICU Medical (ICUI) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ICUI and similar high-potential opportunities.
Latest ICUI Stock Price Targets & Analyst Predictions
Based on our analysis of 9 Wall Street analysts, ICUI has a bullish consensus with a median price target of $187.00 (ranging from $175.00 to $200.00). The overall analyst rating is Strong Buy (8.7/10). Currently trading at $128.99, the median forecast implies a 45.0% upside. This outlook is supported by 5 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Michael Toomey at Jefferies, projecting a 55.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ICUI Analyst Ratings
5
Buy
1
Hold
0
Sell
ICUI Price Target Range
Low
$175.00
Average
$187.00
High
$200.00
Current: $128.99
Latest ICUI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ICUI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 9, 2025 | Raymond James | Jayson Bedford | Strong Buy | Maintains | $187.00 |
| Apr 21, 2025 | Keybanc | Tim Rezvan | Overweight | Maintains | $191.00 |
| Apr 8, 2025 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Dec 11, 2024 | Jefferies | Michael Toomey | Buy | Upgrade | $200.00 |
| Nov 13, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Nov 13, 2024 | Keybanc | Brett Fishbin | Overweight | Maintains | $209.00 |
| Oct 15, 2024 | Keybanc | Brett Fishbin | Overweight | Maintains | $198.00 |
| Oct 14, 2024 | Jefferies | Michael Toomey | Hold | Initiates | $183.00 |
| Oct 10, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Sep 12, 2024 | Raymond James | Jayson Bedford | Outperform | Maintains | $190.00 |
| Aug 8, 2024 | Keybanc | Brett Fishbin | Overweight | Maintains | $147.00 |
| Aug 8, 2024 | Raymond James | Jayson Bedford | Outperform | Maintains | $158.00 |
| Aug 8, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Jun 21, 2024 | Needham | Mike Matson | Hold | Initiates | $0.00 |
| Jun 17, 2024 | Raymond James | Jayson Bedford | Outperform | Upgrade | $135.00 |
| Feb 28, 2024 | Keybanc | Brett Fishbin | Overweight | Maintains | $136.00 |
| Feb 6, 2024 | Keybanc | Brett Fishbin | Overweight | Initiates | $134.00 |
| Dec 14, 2023 | CL King | Kristen Stewart | Buy | Initiates | $110.00 |
| May 9, 2023 | Keybanc | Matthew Mishan | Overweight | Maintains | $216.00 |
| Nov 8, 2022 | Raymond James | Jayson Bedford | Market Perform | Downgrade | $0.00 |
Icu Medical Inc. (ICUI) Competitors
The following stocks are similar to ICU Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ICUI
ICU Medical
mkt cap
3.46B
Icu Medical Inc. (ICUI) Financial Data
Icu Medical Inc. has a market capitalization of $3.17B with a P/E ratio of -26.7x. The company generates $2.42B in trailing twelve-month revenue with a -3.9% profit margin.
Revenue growth is +6.7% quarter-over-quarter, while maintaining an operating margin of +4.9% and return on equity of -4.6%.
Valuation Metrics
Market Cap
$3.17B
Enterprise Value
$4.48B
P/E Ratio
-26.7x
PEG Ratio
18.9x
Price/Sales
1.3x
Growth & Margins
Revenue Growth (YoY)
+6.7%
Gross Margin
+34.7%
Operating Margin
+4.9%
Net Margin
-3.9%
EPS Growth
+6.7%
Financial Health
Cash/Price Ratio
+9.4%
Current Ratio
2.6x
Debt/Equity
80.6x
ROE
-4.6%
ROA
+1.8%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Icu Medical Inc. (ICUI) Business Model
About Icu Medical Inc.
What They Do
Develops innovative medical devices for healthcare.
Business Model
The company generates revenue through the development, manufacturing, and sale of medical devices and systems primarily used in infusion therapy and critical care applications. Their product offerings include infusion pumps, infusion sets, and needle-free connectors, which enhance patient safety and operational efficiency in healthcare facilities.
Additional Information
Icu Medical Inc. is well-established in hospitals and plays a crucial role in intravenous therapy delivery. The company's commitment to research and development has fostered a reputation for high-quality medical solutions, impacting areas like acute care, oncology, and pharmaceuticals. Its performance in the financial market reflects ongoing trends in healthcare innovation.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
15,000
CEO
Mr. Vivek Jain
Country
United States
IPO Year
1992
Website
www.icumed.comIcu Medical Inc. (ICUI) Latest News & Analysis
Latest News
Quick Summary
Pomerantz LLP is investigating claims for ICU Medical, Inc. (NASDAQ: ICUI) investors. Interested parties should contact Danielle Peyton for more information.
Why It Matters
ICU Medical is under investigation, potentially signaling legal issues that could impact stock performance and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Pomerantz LLP is investigating claims for ICU Medical, Inc. (NASDAQ: ICUI) investors. Interested parties should contact Danielle Peyton for more information.
Why It Matters
The investigation by Pomerantz LLP may indicate potential legal issues or financial irregularities at ICU Medical, which could affect stock performance and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICU Medical, Inc. – ICUI
10 days ago
Quick Summary
Pomerantz LLP is investigating claims for ICU Medical, Inc. (NASDAQ: ICUI) investors. Interested parties should contact Danielle Peyton for more information.
Why It Matters
The investigation suggests potential legal issues for ICU Medical, which could impact its stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
ICU Medical, Inc. will hold its Q1 2025 earnings conference call on May 8, 2025, at 4:30 PM ET, featuring key executives and analysts from several firms.
Why It Matters
The earnings call provides insights into ICU Medical's financial performance and strategic direction, influencing stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
ICU Medical Announces First Quarter 2025 Results
15 days ago
Quick Summary
ICU Medical, Inc. (Nasdaq:ICUI) reported its financial results for Q1 2025, ending March 31. Further details on performance were not provided in the excerpt.
Why It Matters
ICU Medical's quarterly financial results can impact stock performance, indicating the company's growth, profitability, and potential future earnings, influencing investor sentiment and decisions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for ICU Medical (NASDAQ:ICUI) investors. Interested parties can find more information at bgandg.com/ICUI.
Why It Matters
An investigation into ICU Medical may indicate potential legal issues or financial irregularities, which could impact stock performance and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Frequently Asked Questions About ICUI Stock
What is Icu Medical Inc.'s (ICUI) stock forecast for 2025?
Based on our analysis of 9 Wall Street analysts, Icu Medical Inc. (ICUI) has a median price target of $187.00. The highest price target is $200.00 and the lowest is $175.00.
Is ICUI stock a good investment in 2025?
According to current analyst ratings, ICUI has 5 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $128.99. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ICUI stock?
Wall Street analysts predict ICUI stock could reach $187.00 in the next 12 months. This represents a 45.0% increase from the current price of $128.99. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Icu Medical Inc.'s business model?
The company generates revenue through the development, manufacturing, and sale of medical devices and systems primarily used in infusion therapy and critical care applications. Their product offerings include infusion pumps, infusion sets, and needle-free connectors, which enhance patient safety and operational efficiency in healthcare facilities.
What is the highest forecasted price for ICUI Icu Medical Inc.?
The highest price target for ICUI is $200.00 from Michael Toomey at Jefferies, which represents a 55.1% increase from the current price of $128.99.
What is the lowest forecasted price for ICUI Icu Medical Inc.?
The lowest price target for ICUI is $175.00 from at , which represents a 35.7% increase from the current price of $128.99.
What is the overall ICUI consensus from analysts for Icu Medical Inc.?
The overall analyst consensus for ICUI is bullish. Out of 9 Wall Street analysts, 5 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $187.00.
How accurate are ICUI stock price projections?
Stock price projections, including those for Icu Medical Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 24, 2025 8:02 AM UTC